Allspring Global Investments’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
VPM
VCM
AC
Allspring Global Investments's HRMY Position: Q1 2026 in Review
Allspring Global Investments increased its Harmony Biosciences (HRMY) stake by 750% in Q1 2026, buying an estimated $5.1M and bringing the position to 176,219 shares worth $4.93M. The position accounts for 0.01% of the portfolio, ranked #865.
Allspring Global Investments first reported a position in HRMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $12.2M in Q4 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.
- Allspring Global Investments held 176,219 shares of Harmony Biosciences worth $4.93M as of Q1 2026.
- Allspring Global Investments bought 155,494 Harmony Biosciences shares in Q1 2026, an estimated $5.1M.
- Harmony Biosciences made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #865 holding.
- Allspring Global Investments first reported a position in Harmony Biosciences in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Harmony Biosciences position peaked at $12.2M in Q4 2022.
- 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.